Completed OBSERVATIONAL NCT04936256

Evaluation of Binocular Visual Acuity and Refractive Stability in the Alcon Clareon Intraocular Lens

Sponsor: Gainesville Eye Associates

Conditions Cataract

Interventions Clareon

Updated 5 times since 2021 Last updated: Aug 1, 2024 Started: Jul 2, 2021 Primary completion: Jul 28, 2022 Completion: Jul 28, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04936256, this observational or N/A phase trial focuses on Cataract and remains completed. Sponsored by Gainesville Eye Associates, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Sep 2022 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Dec 2021 — Sep 2022 [monthly]

Recruiting
Sep 2021 — Dec 2021 [monthly]

Recruiting

First recorded

Jul 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gainesville Eye Associates
Sengi

Data source: Gainesville Eye Associates

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gainesville, United States